• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003 Mar 15; 23(6):1992-6.

View in: PubMed

subject areas
  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Amyloidosis
  • Animals
  • Brain
  • Cell Line
  • Disease Models, Animal
  • Drug Administration Routes
  • Frontal Lobe
  • Gene Transfer Techniques
  • Genes, Reporter
  • Genetic Therapy
  • Genetic Vectors
  • Hippocampus
  • Humans
  • Kidney
  • Lentivirus
  • Mice
  • Mice, Transgenic
  • Neprilysin
  • Peptide Fragments
  • Plaque, Amyloid
  • Stem Cells
  • Treatment Outcome

authors with profiles
  • Mark S. Kindy